nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—liver cancer	0.831	1	CbGaD
Ximelagatran—F2—posterior vena cava—liver cancer	0.0441	0.353	CbGeAlD
Ximelagatran—F2—hepatic artery—liver cancer	0.0389	0.311	CbGeAlD
Ximelagatran—F2—portal vein—liver cancer	0.0338	0.27	CbGeAlD
Ximelagatran—F2—gall bladder—liver cancer	0.00581	0.0465	CbGeAlD
Ximelagatran—F2—liver—liver cancer	0.0017	0.0136	CbGeAlD
Ximelagatran—CYP2C9—liver—liver cancer	0.000679	0.00543	CbGeAlD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR4—liver cancer	0.000346	0.00783	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—liver cancer	0.000341	0.00773	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HBE1—liver cancer	0.000337	0.00764	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP1A1—liver cancer	0.000332	0.00752	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.000329	0.00746	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ALB—liver cancer	0.000329	0.00745	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRIO—liver cancer	0.000327	0.0074	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—PIK3CA—liver cancer	0.000323	0.00733	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1A1—liver cancer	0.000319	0.00724	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ADAMTS17—liver cancer	0.000312	0.00707	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000302	0.00685	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—SERPINE1—liver cancer	0.000293	0.00664	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MTHFR—liver cancer	0.000291	0.0066	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000286	0.00647	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—HPGDS—liver cancer	0.000272	0.00617	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SERPINE1—liver cancer	0.000268	0.00607	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	0.000268	0.00607	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—liver cancer	0.000267	0.00606	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—UGDH—liver cancer	0.00026	0.00588	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—liver cancer	0.000255	0.00579	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—liver cancer	0.000249	0.00565	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—YIF1A—liver cancer	0.000236	0.00536	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.000232	0.00525	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—liver cancer	0.000217	0.00491	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000213	0.00482	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—liver cancer	0.000212	0.00481	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ANXA2—liver cancer	0.000208	0.00472	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—GGT1—liver cancer	0.000204	0.00462	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—liver cancer	0.000203	0.00459	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PRKCE—liver cancer	0.000202	0.00457	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000199	0.0045	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—liver cancer	0.000197	0.00447	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EXOSC2—liver cancer	0.000195	0.00441	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—liver cancer	0.000194	0.0044	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000192	0.00435	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000189	0.00429	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—liver cancer	0.000187	0.00423	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00018	0.00409	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—liver cancer	0.00018	0.00407	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR4—liver cancer	0.000177	0.004	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000176	0.004	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CB—liver cancer	0.000171	0.00387	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000167	0.00379	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000164	0.00372	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000163	0.00369	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—APC—liver cancer	0.000161	0.00364	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CG—liver cancer	0.000161	0.00364	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000159	0.00362	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—liver cancer	0.000158	0.00358	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000158	0.00358	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—liver cancer	0.000157	0.00355	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000156	0.00354	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000156	0.00353	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—NR1H4—liver cancer	0.000152	0.00344	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—BRAF—liver cancer	0.000151	0.00342	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTA3—liver cancer	0.000149	0.00338	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	0.000147	0.00333	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—liver cancer	0.000147	0.00333	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CD—liver cancer	0.000141	0.0032	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—liver cancer	0.000139	0.00316	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINA1—liver cancer	0.000138	0.00313	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000138	0.00312	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTA4—liver cancer	0.000136	0.00309	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000136	0.00308	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.000134	0.00305	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CHN2—liver cancer	0.000134	0.00305	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.000133	0.00301	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.000128	0.00291	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—liver cancer	0.000127	0.00289	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—NAT2—liver cancer	0.000127	0.00287	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000126	0.00286	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—RAF1—liver cancer	0.000126	0.00286	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—liver cancer	0.000125	0.00284	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	0.000125	0.00283	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CB—liver cancer	0.000123	0.00279	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IFT88—liver cancer	0.000123	0.00279	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.000117	0.00266	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—liver cancer	0.000113	0.00257	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000112	0.00253	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ATF3—liver cancer	0.000109	0.00248	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000106	0.00241	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TRIO—liver cancer	0.000104	0.00236	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—liver cancer	0.000104	0.00236	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	0.000103	0.00233	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA1—liver cancer	0.000103	0.00233	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	0.000102	0.00231	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—liver cancer	0.000102	0.0023	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000101	0.0023	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—liver cancer	0.000101	0.00229	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR4—liver cancer	9.98e-05	0.00226	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—liver cancer	9.62e-05	0.00218	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TRIO—liver cancer	9.45e-05	0.00214	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	9.4e-05	0.00213	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	9.37e-05	0.00212	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAF1—liver cancer	9.19e-05	0.00208	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PRKCE—liver cancer	9.09e-05	0.00206	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR4—liver cancer	9.06e-05	0.00205	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	8.98e-05	0.00203	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ABL1—liver cancer	8.65e-05	0.00196	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF2—liver cancer	8.61e-05	0.00195	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2E1—liver cancer	8.26e-05	0.00187	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—liver cancer	8.24e-05	0.00187	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—liver cancer	8.16e-05	0.00185	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	8.15e-05	0.00185	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HGF—liver cancer	8.13e-05	0.00184	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CSF2—liver cancer	8.04e-05	0.00182	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GGT1—liver cancer	7.59e-05	0.00172	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SHC3—liver cancer	7.54e-05	0.00171	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—liver cancer	7.5e-05	0.0017	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—liver cancer	7.01e-05	0.00159	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—liver cancer	6.81e-05	0.00154	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF2—liver cancer	6.77e-05	0.00154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	6.72e-05	0.00152	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK14—liver cancer	6.51e-05	0.00148	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—liver cancer	6.43e-05	0.00146	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—liver cancer	6.26e-05	0.00142	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—liver cancer	6.25e-05	0.00142	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	6.18e-05	0.0014	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	6.09e-05	0.00138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	6.04e-05	0.00137	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—liver cancer	6.04e-05	0.00137	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—liver cancer	5.94e-05	0.00135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	5.85e-05	0.00133	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FST—liver cancer	5.85e-05	0.00133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	5.82e-05	0.00132	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PRKCE—liver cancer	5.74e-05	0.0013	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	5.59e-05	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TRIO—liver cancer	5.58e-05	0.00127	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	5.47e-05	0.00124	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR4—liver cancer	5.35e-05	0.00121	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CD—liver cancer	5.31e-05	0.0012	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE1—liver cancer	5.25e-05	0.00119	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—liver cancer	5.24e-05	0.00119	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRKCE—liver cancer	5.22e-05	0.00118	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	5.18e-05	0.00117	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CSF2—liver cancer	5.08e-05	0.00115	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	4.95e-05	0.00112	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAF1—liver cancer	4.74e-05	0.00107	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—liver cancer	4.63e-05	0.00105	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CSF2—liver cancer	4.61e-05	0.00105	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—liver cancer	4.47e-05	0.00101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.45e-05	0.00101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UGDH—liver cancer	4.44e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—liver cancer	4.25e-05	0.000963	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADAM17—liver cancer	4.23e-05	0.000959	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—liver cancer	4.21e-05	0.000954	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EPT1—liver cancer	4.17e-05	0.000946	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMD10—liver cancer	3.98e-05	0.000902	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMA4—liver cancer	3.98e-05	0.000902	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TAT—liver cancer	3.96e-05	0.000897	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.89e-05	0.000882	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—liver cancer	3.82e-05	0.000865	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—liver cancer	3.61e-05	0.000819	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—liver cancer	3.47e-05	0.000785	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—liver cancer	3.35e-05	0.00076	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—liver cancer	3.31e-05	0.000751	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—liver cancer	3.23e-05	0.000731	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCE—liver cancer	3.08e-05	0.000698	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—liver cancer	3.07e-05	0.000696	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—liver cancer	3.05e-05	0.00069	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—liver cancer	2.92e-05	0.000663	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF2—liver cancer	2.92e-05	0.000662	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.91e-05	0.00066	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—liver cancer	2.82e-05	0.000639	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—liver cancer	2.73e-05	0.000618	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CSF2—liver cancer	2.73e-05	0.000618	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RAF1—liver cancer	2.72e-05	0.000616	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CPT1B—liver cancer	2.69e-05	0.00061	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLUL—liver cancer	2.69e-05	0.00061	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—H2AFX—liver cancer	2.69e-05	0.000609	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—liver cancer	2.69e-05	0.000609	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—liver cancer	2.66e-05	0.000602	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—liver cancer	2.61e-05	0.000591	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NR1H4—liver cancer	2.59e-05	0.000588	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA3—liver cancer	2.55e-05	0.000578	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—liver cancer	2.44e-05	0.000553	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—liver cancer	2.43e-05	0.000551	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA4—liver cancer	2.33e-05	0.000529	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—liver cancer	2.3e-05	0.000522	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.28e-05	0.000517	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA2—liver cancer	2.27e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—liver cancer	2.22e-05	0.000504	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK14—liver cancer	2.21e-05	0.0005	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA1—liver cancer	2.19e-05	0.000497	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT2—liver cancer	2.17e-05	0.000491	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—liver cancer	2.17e-05	0.000491	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.08e-05	0.000473	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDOB—liver cancer	2.08e-05	0.000471	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—liver cancer	2.05e-05	0.000464	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—liver cancer	2.05e-05	0.000464	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CRABP1—liver cancer	1.98e-05	0.000449	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BRAF—liver cancer	1.92e-05	0.000436	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—liver cancer	1.8e-05	0.000408	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.79e-05	0.000405	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—liver cancer	1.78e-05	0.000404	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—liver cancer	1.78e-05	0.000403	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—liver cancer	1.76e-05	0.000399	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGDS—liver cancer	1.73e-05	0.000393	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.72e-05	0.000391	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—liver cancer	1.62e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAF1—liver cancer	1.61e-05	0.000364	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.57e-05	0.000356	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—liver cancer	1.57e-05	0.000356	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—liver cancer	1.57e-05	0.000356	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.55e-05	0.000351	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMA4—liver cancer	1.54e-05	0.00035	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMD10—liver cancer	1.54e-05	0.00035	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GOT2—liver cancer	1.5e-05	0.000341	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—liver cancer	1.5e-05	0.000339	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—liver cancer	1.47e-05	0.000334	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—liver cancer	1.46e-05	0.00033	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—liver cancer	1.44e-05	0.000327	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—liver cancer	1.44e-05	0.000327	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—liver cancer	1.43e-05	0.000325	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2E1—liver cancer	1.41e-05	0.00032	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—liver cancer	1.4e-05	0.000318	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—liver cancer	1.4e-05	0.000318	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—liver cancer	1.39e-05	0.000315	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.37e-05	0.00031	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—liver cancer	1.36e-05	0.000309	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1A—liver cancer	1.36e-05	0.000308	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK8—liver cancer	1.33e-05	0.000301	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—liver cancer	1.32e-05	0.0003	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYCS—liver cancer	1.32e-05	0.0003	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GGT1—liver cancer	1.3e-05	0.000294	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GOT1—liver cancer	1.3e-05	0.000294	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—liver cancer	1.22e-05	0.000277	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—liver cancer	1.21e-05	0.000275	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—liver cancer	1.17e-05	0.000264	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—liver cancer	1.15e-05	0.00026	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—liver cancer	1.13e-05	0.000255	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—liver cancer	1.12e-05	0.000255	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—liver cancer	1.07e-05	0.000243	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—liver cancer	1.04e-05	0.000236	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—liver cancer	1.02e-05	0.00023	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—liver cancer	9.56e-06	0.000217	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—liver cancer	9.46e-06	0.000215	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARA—liver cancer	9.28e-06	0.00021	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—liver cancer	9.25e-06	0.00021	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—liver cancer	8.85e-06	0.000201	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—liver cancer	8.47e-06	0.000192	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.34e-06	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—liver cancer	7.95e-06	0.00018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—liver cancer	7.81e-06	0.000177	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—liver cancer	7.67e-06	0.000174	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—liver cancer	6.99e-06	0.000158	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—liver cancer	6.9e-06	0.000156	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—liver cancer	6.09e-06	0.000138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—liver cancer	3.71e-06	8.42e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—liver cancer	3.03e-06	6.88e-05	CbGpPWpGaD
